Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Cited In for PubMed (Select 17470851)

1.

T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.

An MS, Yoo JH, Kim KH, Bae KB, Choi CS, Hwang JW, Kim JH, Kim BM, Kang MS, Oh MK, Hong KH.

World J Surg Oncol. 2015 Dec;13(1):488. doi: 10.1186/s12957-015-0488-7. Epub 2015 Feb 19.

2.

A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).

Ishihara S, Matsusaka S, Kondo K, Horie H, Uehara K, Oguchi M, Murofushi K, Ueno M, Mizunuma N, Shinbo T, Kato D, Okuda J, Hashiguchi Y, Nakazawa M, Sunami E, Kawai K, Yamashita H, Okada T, Ishikawa Y, Nakajima T, Watanabe T.

Radiat Oncol. 2015 Jan 23;10(1):24. [Epub ahead of print]

3.

Management of colorectal cancer.

Stintzing S.

F1000Prime Rep. 2014 Nov 4;6:108. doi: 10.12703/P6-108. eCollection 2014. Review.

4.

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.

Lindskog EB, Gunnarsdóttir KÁ, Derwinger K, Wettergren Y, Glimelius B, Kodeda K.

BMC Cancer. 2014 Dec 13;14:948. doi: 10.1186/1471-2407-14-948.

5.

Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.

Tan HJ, Meyer AM, Kuo TM, Smith AB, Wheeler SB, Carpenter WR, Nielsen ME.

Cancer. 2015 Mar 15;121(6):836-43. doi: 10.1002/cncr.29144. Epub 2014 Nov 19.

PMID:
25410684
6.

Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAFV600E in Patients with Lymph Node-Positive Colon Cancer.

Zaanan A, Bachet JB, André T, Sinicrope FA.

Curr Colorectal Cancer Rep. 2014 Sep 1;10(3):346-353.

PMID:
25386108
7.

Preoperative chemotherapy for locally advanced resectable colon cancer - a new treatment paradigm in colon cancer?

Zhou Z, Nimeiri HS, Benson AB 3rd.

Ann Transl Med. 2013 Jul;1(2):11. doi: 10.3978/j.issn.2305-5839.2013.01.01. No abstract available.

8.

Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.

Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR.

Gastroenterology. 2015 Jan;148(1):88-99. doi: 10.1053/j.gastro.2014.09.041. Epub 2014 Oct 8.

9.

Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.

Penn DC, Chang Y, Meyer AM, DeFilippo Mack C, Sanoff HK, Stitzenberg KB, Carpenter WR.

Cancer. 2015 Jan 1;121(1):93-101. doi: 10.1002/cncr.29028. Epub 2014 Sep 10.

PMID:
25209056
10.

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort.

Hansen TF, Kjær-Frifeldt S, Christensen RD, Morgenthaler S, Blondal T, Lindebjerg J, Sørensen FB, Jakobsen A.

Br J Cancer. 2014 Sep 23;111(7):1285-92. doi: 10.1038/bjc.2014.409. Epub 2014 Jul 22.

PMID:
25051407
11.

Prognostic and predictive significance of MSI in stages II/III colon cancer.

Saridaki Z, Souglakos J, Georgoulias V.

World J Gastroenterol. 2014 Jun 14;20(22):6809-14. doi: 10.3748/wjg.v20.i22.6809.

12.

Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.

Liang Y, Tang W, Huang T, Gao Y, Tan A, Yang X, Zhang H, Hu Y, Qin X, Li S, Zhang S, Mo L, Liang Z, Shi D, Huang Z, Guan Y, Zhou J, Winkler C, O'Brien SJ, Xu J, Mo Z, Peng T.

PLoS One. 2014 Jun 18;9(6):e97923. doi: 10.1371/journal.pone.0097923. eCollection 2014.

13.

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.

Zaanan A, Dalban C, Emile JF, Blons H, Fléjou JF, Goumard C, Istanbullu M, Calmel C, Alhazmi K, Validire P, Louvet C, de Gramont A, Laurent-Puig P, Taïeb J, Praz F.

J Cancer. 2014 May 2;5(6):425-32. doi: 10.7150/jca.8594. eCollection 2014.

14.

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

O'Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP, Parda DS, Mohiuddin M, Arora A, Evans LS, Bahary N, Soori GS, Eakle J, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Wozniak TF, Roh MS, Yothers G, Wolmark N.

J Clin Oncol. 2014 Jun 20;32(18):1927-34. doi: 10.1200/JCO.2013.53.7753. Epub 2014 May 5.

PMID:
24799484
15.

Sigmoid adenocarcinoma with renal metastasis.

Dagnoni C, Granero LC, Rovere RK.

Clin Pract. 2011 Nov 2;1(4):e88. doi: 10.4081/cp.2011.e88. eCollection 2011 Sep 28.

16.

Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

Mekata E, Sonoda H, Shimizu T, Tatsuta T, Yamaguchi T, Endo Y, Tani T.

Mol Clin Oncol. 2013 Jul;1(4):763-767. Epub 2013 Apr 11.

17.

Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis.

Nebuloni DR, Mak MP, Souza FH, Saragiotto DF, Júlio T, DE Castro G Jr, Sabbaga J, Hoff PM.

Mol Clin Oncol. 2013 Jan;1(1):175-179. Epub 2012 Aug 20.

18.

Predicting clinical trial results based on announcements of interim analyses.

Broglio KR, Stivers DN, Berry DA.

Trials. 2014 Mar 7;15:73. doi: 10.1186/1745-6215-15-73.

19.

Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007.

Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ.

Cancer. 2014 Apr 15;120(8):1162-70. doi: 10.1002/cncr.28545. Epub 2014 Jan 28.

PMID:
24474245
20.

Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?

Joshi R.

South Asian J Cancer. 2013 Apr;2(2):70-1. doi: 10.4103/2278-330X.110490. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk